Clinical Trial Update: Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of doxorubicin and gemcitabine in locally recurrent or unresectable metastatic renal cell carcinoma (including sarcomatoid features) completed; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Renal Cell Carcinoma with Sarcomatoid Features

Drugs mentioned

• Doxorubicin (doxorubicin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features | Phase 2 | Status: COMPLETED | Results posted: 2013-01-04